GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » Cyclically Adjusted Price-to-FCF

Divi's Laboratories (NSE:DIVISLAB) Cyclically Adjusted Price-to-FCF : 122.86 (As of Apr. 29, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-04-29), Divi's Laboratories's current share price is ₹4016.35. Divi's Laboratories's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar23 was ₹32.69. Divi's Laboratories's Cyclically Adjusted Price-to-FCF for today is 122.86.

The historical rank and industry rank for Divi's Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

NSE:DIVISLAB' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 86.37   Med: 145.78   Max: 222.74
Current: 122.86

During the past 13 years, Divi's Laboratories's highest Cyclically Adjusted Price-to-FCF was 222.74. The lowest was 86.37. And the median was 145.78.

NSE:DIVISLAB's Cyclically Adjusted Price-to-FCF is ranked worse than
84.31% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs NSE:DIVISLAB: 122.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Divi's Laboratories's adjusted free cash flow per share data of for the fiscal year that ended in Mar23 was ₹74.838. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₹32.69 for the trailing ten years ended in Mar23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Divi's Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Divi's Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Cyclically Adjusted Price-to-FCF Chart

Divi's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.07 125.82 186.18 178.36 86.37

Divi's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 86.37 - - -

Competitive Comparison of Divi's Laboratories's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Cyclically Adjusted Price-to-FCF falls into.



Divi's Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Divi's Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=4016.35/32.69
=122.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar23 is calculated as:

For example, Divi's Laboratories's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar23 (Change)*Current CPI (Mar23)
=74.838/146.8646*146.8646
=74.838

Current CPI (Mar23) = 146.8646.

Divi's Laboratories Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 11.689 91.425 18.777
201503 19.555 97.163 29.558
201603 24.188 102.518 34.651
201703 29.144 105.196 40.688
201803 18.909 109.786 25.295
201903 8.334 118.202 10.355
202003 1.233 124.705 1.452
202103 39.053 131.771 43.526
202203 45.150 138.822 47.766
202303 74.838 146.865 74.838

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Divi's Laboratories  (NSE:DIVISLAB) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Divi's Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Divi's Laboratories (NSE:DIVISLAB) Business Description

Traded in Other Exchanges
Address
Divi Towers, 1-72/23(P)/DIVIS/303, Babukhan Lane, Cyber Hills, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. Most of the company's sales are generated in Europe, followed by North America, India, and Asia. The company has three distinct business segments: Generic APIs, Custom Synthesis, and Nutraceuticals. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Divi's Laboratories (NSE:DIVISLAB) Headlines

No Headlines